Table 2.
Univariate meta-regression analysis between effect size and possible contributors to heterogeneity.
| Parameter | N | T | p |
|---|---|---|---|
| Age | 34 | -1.38 | 0.18 |
| Gender | 35 | 0.06 | 0.95 |
| White blood cell count | 31 | -0.06 | 0.95 |
| Neutrophils | 26 | 1.01 | 0.32 |
| Lymphocytes | 33 | 1.61 | 0.12 |
| C-reactive protein | 28 | 2.07 | 0.048 |
| Procalcitonin | 13 | 1.81 | 0.10 |
| Aspartate aminotransferase | 27 | -0.27 | 0.79 |
| Alanine aminotransferase | 29 | -1.19 | 0.24 |
| Albumin | 23 | 0.08 | 0.94 |
| D-Dimer | 26 | 3.72 | 0.001 |
| Troponin | 11 | 2.17 | 0.06 |
| Creatine kinase | 13 | 1.44 | 0.18 |
| Creatinine | 25 | 0.13 | 0.90 |
| Urea | 22 | 0.16 | 0.88 |
| Lactate dehydrogenase | 22 | 1.20 | 0.24 |
| Glucose | 11 | 1.02 | 0.33 |
| Activated partial thromboplastin time | 24 | -0.11 | 0.91 |
| Fibrinogen | 21 | -0.69 | 0.50 |
| Diabetes | 22 | -0.33 | 0.74 |
| Cardiovascular disease | 19 | 0.08 | 0.94 |
| Hypertension | 18 | -0.32 | 0.75 |